• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肝细胞癌的胃肠道累及：两例十二指肠和食管侵犯病例说明。

Gastrointestinal tract involvement in hepatocellular carcinoma: two cases illustrating duodenal and oesophageal invasion.

机构信息

Service d'Hépato-gastroentérologie, Centre Hospitalier de Wallonie Picarde, Tournai, Belgium.

出版信息

Acta Gastroenterol Belg. 2021 Oct-Dec;84(4):660-662. doi: 10.51821/84.4.017.

DOI:10.51821/84.4.017
PMID:34965048
Abstract

We present here two hepatocellular carcinoma (HCC) patients with gastrointestinal tract involvement (GITI). Hemorrhage due to duodenal involvement was the inaugural event of the HCC for the first patient. Dysphagia due to HCC recurrence in the oesophagus four years after left hepatectomy was the call symptom for the second. As incidence of HCC increases, and overall survival improves, incidence of GITI in HCC patients is expected to increase.

摘要

我们在此介绍两位合并胃肠道累及（GITI）的肝细胞癌（HCC）患者。对于第一位患者，十二指肠受累导致的出血是 HCC 的首发事件。第二位患者在左肝切除四年后因 HCC 复发出现吞咽困难。随着 HCC 发病率的增加和总体生存率的提高，预计 HCC 患者中 GITI 的发病率也会增加。

相似文献

1
Gastrointestinal tract involvement in hepatocellular carcinoma: two cases illustrating duodenal and oesophageal invasion.肝细胞癌的胃肠道累及：两例十二指肠和食管侵犯病例说明。
Acta Gastroenterol Belg. 2021 Oct-Dec;84(4):660-662. doi: 10.51821/84.4.017.
2
Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.微血管侵犯模式影响肝细胞癌患者二次肝切除术后的生存情况。
J Surg Res. 2016 Jan;200(1):82-90. doi: 10.1016/j.jss.2015.06.069. Epub 2015 Jul 9.
3
Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.手术对微血管侵犯阴性肝细胞癌患者无复发生存率的影响
J Am Coll Surg. 2009 Mar;208(3):368-74. doi: 10.1016/j.jamcollsurg.2008.10.031.
4
Repeat hepatectomy for recurrent hepatocellular carcinoma.复发性肝细胞癌的再次肝切除术
Surgery. 2007 May;141(5):589-97. doi: 10.1016/j.surg.2006.12.014.
5
Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma.预测肝细胞癌根治性肝切除术后复发和生存的侵袭性评分方案
Surgery. 1997 Sep;122(3):571-7. doi: 10.1016/s0039-6060(97)90130-6.
6
[Surgical treatment of primary liver cancer:a report of 10 966 cases].[原发性肝癌的外科治疗：10966例报告]
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):6-17. doi: 10.3760/cma.j.cn112139-20201110-00791.
7
Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.肝细胞癌根治性肝切除术后浆膜侵犯与复发密切相关：214例连续病例的回顾性研究
Medicine (Baltimore). 2015 Mar;94(9):e602. doi: 10.1097/MD.0000000000000602.
8
Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study.血清代谢物可作为评估血管侵犯和识别行肝切除术的肝细胞癌中正常甲胎蛋白的有用标志物：一项初步研究。
World J Surg Oncol. 2020 Jun 3;18(1):121. doi: 10.1186/s12957-020-01885-w.
9
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.复发性肝细胞癌患者再次肝切除术的选择标准。
Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.
10
Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.多灶性肝细胞癌肝切除术后及后续多模式治疗复发的结果。
Br J Surg. 2013 Oct;100(11):1516-22. doi: 10.1002/bjs.9263.

引用本文的文献

1
Hepatocellular Carcinoma with Gastrointestinal Involvement: A Systematic Review.伴有胃肠道受累的肝细胞癌：一项系统综述
Diagnostics (Basel). 2022 May 19;12(5):1270. doi: 10.3390/diagnostics12051270.